Serum level of fibroblast growth factor 23 in maintenance renal transplant patients. - Wikidata - wikimedia - TriplyDB

Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.

Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.

http://www.wikidata.org/entity/Q51301290

about

Vascular calcification, bone and mineral metabolism after kidney transplantation Impact of FGF23 level on calcium and phosphorus levels in post-renal transplantation.FGF-23, Klotho and Vitamin D Levels in Scleroderma Long term evolution of endothelial function during kidney transplantation.Phosphocalcic Markers and Calcification Propensity for Assessment of Interstitial Fibrosis and Vascular Lesions in Kidney Allograft Recipients.More than skin deep? Potential nicotinamide treatment applications in chronic kidney transplant recipients.Bone and mineral disorders after kidney transplantation: therapeutic strategies The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone Disorder.Phosphate and FGF-23 homeostasis after kidney transplantation.Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort.Fibroblast Growth Factor 23: Mineral Metabolism and Beyond.Vitamin D in patients with chronic kidney disease: a position statement of the Working Group "Trace Elements and Mineral Metabolism" of the Italian Society of Nephrology.Longitudinal assessment of cardiac morphology and function following kidney transplantation.FGF23 in kidney transplant: the strange case of Doctor Jekyll and Mister Hyde.Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation.

P2860

Q26771400-0907C7AD-0BE6-46F7-BBA9-A6236497F8A9 Q33652345-5941B0C3-5216-4BD2-828F-85D6C4C6EC13 Q33711101-18CB5755-A8BD-4913-871E-EC6AC9B07748 Q36172106-F8E0EA99-67CC-4A44-91A8-A96EA95335D2 Q36236289-920EF7F7-B40C-4932-BA17-D5E13BD1FEA0 Q37522572-7B4ACC85-FB00-43BC-A34E-9F7BB0F37388 Q38181757-1996B110-050F-48F5-90E9-E6E5D136811E Q38584122-FC43E630-CA86-4817-9A96-675DB520FB83 Q38594874-4589C014-55C4-481F-9582-56B53A7C98B3 Q38745657-766726F1-4DFD-4FCD-A359-B8B145FB5723 Q38768746-747B85D9-CA05-45B9-852A-8C69639A42B3 Q38803449-931E0943-4B58-446A-9F66-C23377DF9B46 Q40500215-45A67BF3-9117-4201-8FAF-7F0CA2EF3563 Q41186366-9EE42740-BD5A-40AB-BC77-7AF3F7BD6B34 Q52894312-4A4C4CE8-4B9E-4968-A6D1-B46233486017 Q55496554-85E16A71-043E-42DB-AD73-92321636D4AE

P2860

Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.

http://www.wikidata.org/entity/Q51301290

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.

@en

Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.

@nl

type

label

Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.

@en

Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.

@nl

prefLabel

Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.

@en

Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.

@nl

P1433

Q51301290-2D42F23B-4263-4E29-90B1-3970F7567879

P1476

Q51301290-8FEDFD48-C656-4991-A9F9-BA2D6F33F9E0

P2093

Q51301290-1BEBBC8C-594E-4945-A7E9-34440E60D658

Q51301290-25A43499-97A1-4236-AA31-9CD2755715C5

Q51301290-48A545C0-6802-4264-A8F2-009BFEA94838

Q51301290-52FFCDAF-8CC9-430E-958B-355E18DCD8D3

Q51301290-5E7B70F8-7123-4AAD-B8C1-03496C78C210

Q51301290-A6A14019-252C-4BE8-8668-12F9F4F40D5E

Q51301290-D2D15995-895E-48EC-8545-B6928467D901

Q51301290-D7D484FD-1D61-40D6-9299-9B9992E62444

P2860

Q51301290-033CF525-6FCD-411C-9421-878868B9E0F0

Q51301290-05B728FF-4A72-4DC4-ACA1-A52BF7E7278A

Q51301290-09F54A1F-3B57-4BEE-8A2A-922AB47423BB

Q51301290-107988C7-2E04-4385-93E3-2FC94BAB8D4D

Q51301290-1DB0291A-7BDC-4CA6-8459-D427DBD1C06F

Q51301290-1EC6C8B1-E9AF-45E3-B3CF-589663DBA862

Q51301290-251A7EA0-E4F8-4492-B41D-BDD261FD4410

Q51301290-375832BC-E430-4563-9408-B55167882685

Q51301290-4319CEB6-96F6-4D84-8BA3-868551D462DD

Q51301290-50331863-0767-4382-A089-1FAD9F3BFC00

P304

Q51301290-F4BCB5AF-1C81-4EFE-B7A6-CE784EE43220

P31

Q51301290-D776247F-71F1-4700-9D7C-9155DED1CAE1

P356

Q51301290-8ED59605-9837-42B0-B395-62455E8E0545

P407

Q51301290-50C3E360-E605-447F-918C-C31BE0D11462

P433

Q51301290-FC6D85CA-C576-4970-835E-1F44B036B636

P478

Q51301290-3BBECAE5-2CE8-4BAE-8783-A85F99C51A3E

P50

Q51301290-60B15981-0742-4E21-AFC8-0BF9B6D2091C

Q51301290-74C57DF5-004D-448A-9792-C127555A86FF

Q51301290-8ADA4728-6375-461D-9E63-2D276C2AFA6F

Q51301290-9AA51764-27CD-4D94-9D83-E935CABDCCFC

Q51301290-E4950896-F964-4F69-8065-26951124BD27

P577

Q51301290-EC4D0D0F-5E37-477E-86BC-AF27A5EAB441

P5875

Q51301290-991B317B-AAE4-4576-BE0C-39C3449EEE9F

P698

Q51301290-33E03213-D06B-404F-95AD-B5232377DFAC

P356

P1433

Nephrology Dialysis Transplantation

P1476

Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.

@en

P2093

Alberto Barrientos

http://www.w3.org/2001/XMLSchema#string

Francisco Valga

http://www.w3.org/2001/XMLSchema#string

Isabel Pérez-Flores

http://www.w3.org/2001/XMLSchema#string

Jose C De la Flor

http://www.w3.org/2001/XMLSchema#string

Maria L Maestro

http://www.w3.org/2001/XMLSchema#string

Natividad Calvo

http://www.w3.org/2001/XMLSchema#string

Rosalía Valero

http://www.w3.org/2001/XMLSchema#string

Virginia De la Orden

http://www.w3.org/2001/XMLSchema#string

P2860

How fibroblast growth factor 23 works

The parathyroid is a target organ for FGF23 in rats

Regulation of fibroblast growth factor-23 signaling by klotho

Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

Fibroblast growth factor-23 and parathyroid hormone are associated with post-transplant bone mineral density loss.

Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation.

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.

P304

4227-4235

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFS409

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Ana Isabel Sanchez Fuctuoso

Cristina Fernández Pérez

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233396249

http://www.w3.org/2001/XMLSchema#string

P698

23144073

http://www.w3.org/2001/XMLSchema#string